Decoding TGF-beta signaling pathways in skin langerhans cells
Decoding TGF-beta signaling pathways in skin langerhans cells
批准号:
10541915
负责人:
QING-SHENG MI
金额:
$37.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-02-01 至 2024-01-31
关键词:
AdultAffectAmino AcidsAntigen-Presenting CellsBCL2 geneBindingBiologyBirthBone MarrowCell MaintenanceCell NucleusCell OntogenyCell physiologyCellular biologyChIP-seqCytoplasmDataDefectDendritic CellsDevelopmentDiseaseEmbryoEmbryonic DevelopmentEpidermisFRAP1 geneFamilyFetal LiverGene ActivationGene DeletionGene MutationGenesGeneticGoalsGrowthHomeostasisITGAM geneImageImmune ToleranceImpairmentIn VitroIndividualInflammationInflammatoryInterruptionLangerhans cellLeadLentivirusLightMAPK8 geneMacrophage Colony-Stimulating Factor ReceptorMaintenanceMediatingMembraneMitogen-Activated Protein KinasesMolecularMusMyelogenousPathway interactionsPeripheralPhosphorylationPhosphotransferasesPopulationProceduresProteinsRUNX3 geneRegulationReportingResearchRoleSignal PathwaySignal TransductionSkinSpecificityTF geneTGF Beta Signaling PathwayTRAF6 geneTestingTransforming Growth Factor betaTransforming Growth FactorsWorkYolk Sacactivating transcription factor 3adaptive immunityblastomere structuredensityexperiencegene functiongene networkin vivomacrophagemonocytemouse modelp38 Mitogen Activated Protein Kinasepostnatalpregnantpromoterreceptorrecruitself-renewalsingle-cell RNA sequencingskin disordertherapeutic targettranscriptome sequencing
中文摘要
摘要
朗格汉斯细胞(LC),皮肤驻留树突状细胞(DC),控制适应性免疫和免疫功能。
和皮肤中的免疫耐受性,并参与多种皮肤疾病的发展。
转化生长因子-β1(Transforming growth factor-β 1,TGFβ1)是维持LC功能的关键因子。
TGFβ1通过与TGF β受体相互作用来激活Smad依赖性或
Smad非依赖性途径调节TGF β 1靶基因和细胞功能。但
信号通路,TGF β 1介导的LC维持的详细分子网络,
TGF β 1在胚胎LC中的作用及其相关机制
发展仍不明朗。我们最近的工作和初步研究表明,TGF β 1是
胚胎LC发育所必需的,其中TGFβ激活的激酶1(Tak 1),和
主导TGFb 1信号通路的是Tak 1,而不是Smads;
LC出生后分化; Smad信号通路在炎症过程中占主导地位-
诱导LC再增殖。这些结果有力地表明,不同的TGF β信号通路,
介导LC调节胚胎个体发育与出生后的稳态或炎症-
诱导繁殖。在拟议的研究中,将使用不同的空间和时间特定的,
瞬时诱导基因突变小鼠模型与RNA-seq、scRNA-seq、ChIP-Seq、
成像FACS和体内/体外慢病毒介导的基因激活和缺失策略,
目的是破译TGF β信号通路和相关的环境依赖性特异性,
调节LC个体发育、出生后体内平衡和再增殖的分子网络。结果
从拟议的研究不仅将进一步我们了解LC生物学,而且将摆脱
对治疗LC相关的高特异性潜在治疗靶点的新认识
疾病
英文摘要
Abstract
Langerhans cells (LCs), the skin residing dendritic cells (DCs), control both adaptive immunity
and immune tolerance in skin and are involved in the development of a variety of skin diseases.
Transforming growth factor-β1 (TGFβ1) is a crucial factor for LC maintenance and function.
TGFβ1 signals through interactions with TGFb receptors to activate either Smad-dependent or
Smad-independent pathways to regulate TGFb1 target genes and cellular function. However, the
signaling pathways, the detailed molecular networks of TGFb1-mediated LC maintenance and
functional regulation, and the specific role of TGFb1 and related mechanisms in embryonic LC
development remain unclear. Our recent work and preliminary studies showed that TGFb1 is
absolutely required for embryonic LC development, in which TGFβ-activated kinase 1 (Tak1), and
not Smads, leads the dominant TGFb1 signaling pathway; that Tak1, not Smads, is involved in
LC postnatal differentiation; and that Smad signaling pathways are dominant during inflammation-
induced LC repopulation. These results strongly suggest that diverse TGFb signaling pathways
mediate LC regulations in embryonic ontogeny versus postnatal homeostasis or inflammation-
induced repopulation. In the proposed studies, will use different spatial- and temporal-specific and
transient inducible gene mutation mouse models combined with RNA-seq, scRNA-seq, ChIP-Seq,
imaging FACS, and in vivo/in vitro lentivirus-mediated gene activation and deletion strategies,
aiming to decipher the context-dependent specificities of TGFb signaling pathways and related
molecular networks that regulate LC ontogeny, postnatal homeostasis, and repopulation. Results
from the proposed studies will not only further our understanding of LC biology, but also will shed
new light on potential therapeutic targets with high specificity for the treatment of LC-related
diseases.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3390/biology12070925
发表时间:
2023-06-28
期刊:
Biology
影响因子:
4.2
作者:
[]
通讯作者:
Roles of HDAC3 in Epidermal Langerhans Cell Ontogeny and Function
-
批准号:9888305
-
项目类别:
-
资助金额:$33.11万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
microRNAs and NKT cell development and function
-
批准号:9241970
-
项目类别:
-
资助金额:$37.42万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Serum miRNA Biomarkers of Islet Autoimmunity
-
批准号:9080976
-
项目类别:
-
资助金额:$77.37万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Roles of HDAC3 in Epidermal Langerhans Cell Ontogeny and Function
-
批准号:9222709
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Serum miRNA Biomarkers of Islet Autoimmunity
-
批准号:9248240
-
项目类别:
-
资助金额:$75.19万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
Roles of HDAC3 in epidermal Langerhans cell ontogeny and function
-
批准号:9082306
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2016
-
负责人:QING-SHENG MI
-
依托单位:
microRNAs and NKT cell development and function
-
批准号:9098864
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2015
-
负责人:QING-SHENG MI
-
依托单位:
microRNA as biomarkers for the response to immunotherapy in melanoma
-
批准号:8383931
-
项目类别:
-
资助金额:$15.93万
-
财政年份:2012
-
负责人:QING-SHENG MI
-
依托单位:
microRNA as biomarkers for the response to immunotherapy in melanoma
-
批准号:8549182
-
项目类别:
-
资助金额:$17.97万
-
财政年份:2012
-
负责人:QING-SHENG MI
-
依托单位:
miRNAs and epidermal langerhans cell development and function
-
批准号:7979036
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2010
-
负责人:QING-SHENG MI
-
依托单位:
miRNAs and epidermal langerhans cell development and function
-
批准号:8131739
-
项目类别:
-
资助金额:$16.07万
-
财政年份:2010
-
负责人:QING-SHENG MI
-
依托单位:
海外基金